{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:42:10Z","timestamp":1789069330995,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To describe utilization patterns of antiepileptic drugs (AEDs) among adult epileptic patients at a tertiary hospital in Oman.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected retrospectively from January 2006 to December 2009. The study included all adult (&amp;gt;18 years) epileptic patients on AEDs and followed up at a neurology clinic at Sultan Qaboos University Hospital in Oman. All reported therapeutic drug monitoring (TDM) requests for serum AED concentrations were also collected. Institutional ethical approval was sought and obtained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key findings<\/jats:title><jats:p>The study included a total of 372 patients with a mean age of 34 \u00b1 15 years. Monotherapy AEDs accounted for 53% of the prescriptions, whereas polytherapy with two or three AED combinations accounted for 27% and 20% respectively. The most frequently prescribed AED was sodium valproate (27%) followed by carbamazepine (23%). The commonly prescribed AED combinations were sodium valproate with clonazepam (12%) followed by sodium valproate with lamotrigine (12%). Evaluation of 574 TDM requests for three AEDs showed that 57% of carbamazepine, 78% of phenytoin and 54% of valproic acid requests were either above or below the recommended therapeutic threshold. Most of these requests were ordered from the hospital's emergency department for suspected insufficient serum concentrations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Antiepileptic drug monotherapy is still the most frequently employed therapeutic strategy in adult patients with epilepsy in keeping with the standard therapeutic guidelines. Sodium valproate is commonly used for different types of seizures reflecting its wide spectrum of anticonvulsant potential. Newer AED utilizations are becoming increasingly popular in our subjects particularly as add-on with other standard AEDs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.2042-7174.2012.00240.x","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T20:27:38Z","timestamp":1346099258000},"page":"117-122","source":"Crossref","is-referenced-by-count":12,"title":["Utilization patterns of antiepileptic drugs among adult epileptic patients at a tertiary hospital in Oman"],"prefix":"10.1093","volume":"21","author":[{"given":"Mohammed","family":"Al Za'abi","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowayda","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al Asmi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sultan Qaboos University Hospital, Al Khoud, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Al-Zakwani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,27]]},"reference":[{"key":"2021020206552891100_ijpp240-bib-0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy \u2013 a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res"},{"key":"2021020206552891100_ijpp240-bib-0002","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/j.1528-1167.2009.02058.x","article-title":"A systematic review of the epidemiology of epilepsy in Arab countries","volume":"50","author":"Benamer","year":"2009","journal-title":"Epilepsia"},{"key":"2021020206552891100_ijpp240-bib-0003","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.jcbfm.9600265","article-title":"Epilepsy: a review of selected clinical syndromes and advances in basic science","volume":"26","author":"Stafstrom","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"2021020206552891100_ijpp240-bib-0004","volume-title":"Epilepsy, Fact Sheet No 999","author":"World Health Organization","year":"2009"},{"key":"2021020206552891100_ijpp240-bib-0005","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1528-1167.2008.01564.x","article-title":"Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City","volume":"49","author":"Benn","year":"2008","journal-title":"Epilepsia"},{"key":"2021020206552891100_ijpp240-bib-0006","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11910-009-0047-0","article-title":"Alternative approaches to epilepsy treatment","volume":"9","author":"McElroy-Cox","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2021020206552891100_ijpp240-bib-0007","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.eplepsyres.2009.08.017","article-title":"Brain stimulation for surgical epilepsy","volume":"89","author":"Jobst","year":"2010","journal-title":"Epilepsy Res"},{"key":"2021020206552891100_ijpp240-bib-0008","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nurt.2008.12.003","article-title":"Electrical stimulation for the treatment of epilepsy","volume":"6","author":"Boon","year":"2009","journal-title":"Neurother"},{"key":"2021020206552891100_ijpp240-bib-0009","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eplepsyres.2005.10.003","article-title":"The ketogenic diet: from molecular mechanisms to clinical effects","volume":"68","author":"Freeman","year":"2006","journal-title":"Epilepsy Res"},{"key":"2021020206552891100_ijpp240-bib-0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nurt.2009.01.005","article-title":"Ketogenic diets: evidence for short- and long-term efficacy","volume":"6","author":"Kossoff","year":"2009","journal-title":"Neurother"},{"key":"2021020206552891100_ijpp240-bib-0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1528-1167.2008.01452.x","article-title":"Management of a first seizure. General conclusions and recommendations","volume":"49","author":"Beghi","year":"2008","journal-title":"Epilepsia"},{"key":"2021020206552891100_ijpp240-bib-0012","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2165\/00003495-200868140-00001","article-title":"Pharmacological management of epilepsy: recent advances and future prospects","volume":"68","author":"Johannessen Landmark","year":"2008","journal-title":"Drugs"},{"key":"2021020206552891100_ijpp240-bib-0013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jocn.2007.02.008","article-title":"Pharmacotherapy of epilepsy: new armamentarium, new issues","volume":"14","author":"Vajda","year":"2007","journal-title":"J Clin Neurosci"},{"key":"2021020206552891100_ijpp240-bib-0014","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.bcp.2009.08.005","article-title":"Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation","volume":"78","author":"Boison","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"2021020206552891100_ijpp240-bib-0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1079335","article-title":"Considerations in the choice of an antiepileptic drug in the treatment of epilepsy","volume":"28","author":"Azar","year":"2008","journal-title":"Semin Neurol"},{"key":"2021020206552891100_ijpp240-bib-0016","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"issue":"11","key":"2021020206552891100_ijpp240-bib-0017","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.60.11_suppl_4.S2","article-title":"Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy","volume":"60","author":"Kwan","year":"2003","journal-title":"Neurology"},{"key":"2021020206552891100_ijpp240-bib-0018","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S1092852900008476","article-title":"Drug treatment of epilepsy: when does it fail and how to optimize its use?","volume":"9","author":"Kwan","year":"2004","journal-title":"CNS Spectr"},{"key":"2021020206552891100_ijpp240-bib-0019","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/14656561003709755","article-title":"Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last","volume":"11","author":"Cretin","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"2021020206552891100_ijpp240-bib-0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1528-1167.2008.01713.x","article-title":"Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam","volume":"50","author":"Kaminski","year":"2009","journal-title":"Epilepsia"},{"key":"2021020206552891100_ijpp240-bib-0021","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003088-200645040-00002","article-title":"Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age","volume":"45","author":"Perucca","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"2021020206552891100_ijpp240-bib-0022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","article-title":"Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy","volume":"107","author":"Privitera","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"2021020206552891100_ijpp240-bib-0023","first-page":"96","article-title":"New antiepileptic drugs \u2013 an overview","volume":"50","author":"Sendrowski","year":"2005","journal-title":"Rocz Akad Med Bialymst"},{"key":"2021020206552891100_ijpp240-bib-0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0404.2006.00705.x","article-title":"Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?","volume":"114","author":"Zaccara","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"2021020206552891100_ijpp240-bib-0025","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","article-title":"Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"2021020206552891100_ijpp240-bib-0026","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(04)00882-8","article-title":"Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines","volume":"3","author":"Beghi","year":"2004","journal-title":"Lancet Neurol"},{"key":"2021020206552891100_ijpp240-bib-0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2710.2002.00429.x","article-title":"Drug utilization pattern of anti-epileptic drugs: a pharmacoepidemiologic study in Oman","volume":"27","author":"Hanssens","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"2021020206552891100_ijpp240-bib-0028","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe \u2013 a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"key":"2021020206552891100_ijpp240-bib-0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/0002512-200926020-00007","article-title":"Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue","volume":"26","author":"Beghi","year":"2009","journal-title":"Drugs Aging"},{"key":"2021020206552891100_ijpp240-bib-0030","first-page":"1541","article-title":"A study on drug use evaluation of anti-epileptics at a multispecialty tertiary care teaching hospital","volume":"1","author":"ArulKumaran","year":"2009","journal-title":"Int J PharTech Res"},{"key":"2021020206552891100_ijpp240-bib-0031","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.seizure.2003.10.002","article-title":"Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy","volume":"13","author":"Moran","year":"2004","journal-title":"Seizure"},{"key":"2021020206552891100_ijpp240-bib-0032","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1600-0404.2001.00197.x","article-title":"Antiepileptic drug utilization: a Danish prescription database analysis","volume":"104","author":"Rochat","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"2021020206552891100_ijpp240-bib-0033","volume-title":"Facts & Figures 2009","author":"Ministry of National Economy","year":"2010"},{"key":"2021020206552891100_ijpp240-bib-0034","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"2021020206552891100_ijpp240-bib-0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"2021020206552891100_ijpp240-bib-0036","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pds.1871","article-title":"Antiepileptic drugs in Australia: 2002-2007","volume":"19","author":"Hollingworth","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021020206552891100_ijpp240-bib-0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.07.005","article-title":"Antiepileptic drugs in epilepsy and other disorders \u2013 a population-based study of prescriptions","volume":"87","author":"Johannessen Landmark","year":"2009","journal-title":"Epilepsy Res"},{"key":"2021020206552891100_ijpp240-bib-0038","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2009.03.002","article-title":"Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003\u20132005","volume":"85","author":"Alacqua","year":"2009","journal-title":"Epilepsy Res"},{"key":"2021020206552891100_ijpp240-bib-0039","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"issue":"24","key":"2021020206552891100_ijpp240-bib-0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/01.wnl.0000302370.01359.8f","article-title":"Monotherapy in adults and elderly persons","volume":"69","author":"Faught","year":"2007","journal-title":"Neurology"},{"key":"2021020206552891100_ijpp240-bib-0041","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2008.11.018","article-title":"Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database","volume":"84","author":"Hsieh","year":"2009","journal-title":"Epilepsy Res"},{"key":"2021020206552891100_ijpp240-bib-0042","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5414\/CPP44438","article-title":"Differences between prescribed daily doses and defined daily doses of antiepileptics \u2013 therapeutic drug monitoring as a marker of the quality of the treatment","volume":"44","author":"Koristkova","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2021020206552891100_ijpp240-bib-0043","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00007691-199410000-00004","article-title":"Plasma antiepileptic drug monitoring in a neurological practice: a 25-year experience","volume":"16","author":"Eadie","year":"1994","journal-title":"Ther Drug Monit"},{"key":"2021020206552891100_ijpp240-bib-0044","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs \u2013 best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"2021020206552891100_ijpp240-bib-0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2165\/00003088-199631020-00004","article-title":"Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring","volume":"31","author":"Yukawa","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"2021020206552891100_ijpp240-bib-0046","first-page":"RA173","article-title":"Limited place for plasma monitoring of new antiepileptic drugs in clinical practice","volume":"14","author":"Striano","year":"2008","journal-title":"Med Sci Monit"},{"key":"2021020206552891100_ijpp240-bib-0047","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1111\/j.1365-2125.2001.00394.x","article-title":"Therapeutic drug monitoring \u2013 antiepileptic drugs","volume":"52","author":"Eadie","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"2021020206552891100_ijpp240-bib-0048","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/ph3061909","article-title":"Therapeutic drug monitoring of the newer anti-epilepsy medications","volume":"3","author":"Krasowski","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"2021020206552891100_ijpp240-bib-0049","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clin Pharmacokinet"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7174.2012.00240.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/21\/2\/117\/36164083\/ijpp240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/21\/2\/117\/36164083\/ijpp240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T19:09:32Z","timestamp":1714331372000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/21\/2\/117\/6102073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,27]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,8,27]]},"published-print":{"date-parts":[[2013,3,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7174.2012.00240.x","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4]]},"published":{"date-parts":[[2012,8,27]]}}}